Acción Walgreens Boots Alliance (WBA)
Empresa de consumo básico. Aquí tienes el precio, un resumen del negocio y lo que conviene saber sobre Walgreens Boots Alliance en septiembre 2026.
Walgreens Boots Alliance, Inc. is an integrated healthcare, pharmacy and retailing company. The Company’s segments include U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment includes the Walgreens business, which includes the operations of retail drug stores, health and wellness services, and specialty and home delivery pharmacy services, and its equity method investment in Cencora, Inc. The International segment consists of pharmacy-led health and beauty retail businesses outside the United States and a pharmaceutical wholesaling and distribution business in Germany. The pharmacy-led health and beauty retail businesses include Boots branded stores in the United Kingdom, the Republic of Ireland and Thailand, and the Benavides brand in Mexico. The Company's U.S. Healthcare segment is a consumer-centric, technology-enabled healthcare business that engages consumers through a personalized, omni-channel experience across the care journey.
Rendimiento del crecimiento a seis meses
Resumen del rendimiento de la acción
Calificación de los analistas
Analysts suggest maintaining Walgreens Boots stock, with a target price of $13.71 indicating potential growth.
Salud financiera
Walgreens Boots Alliance is generating stable revenue and cash flow, but profit margins are relatively low.
Dividendo
Walgreens Boots Alliance's high dividend yield of 8.73% is appealing for those seeking dividend income. If you invested $1000 you would be paid $87.30 a year in dividends (based on the last 12 months).
¿Por qué invertir con Nemo?
Cero comisiones
Opera acciones, ETF y más sin comisiones. Conserva una mayor parte de tus ganancias.
Confiable y regulado
Parte del grupo Exinity desde 2015, con más de un millón de clientes en todo el mundo.